ClearPoint Neuro/$CLPT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About ClearPoint Neuro
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.
Ticker
$CLPT
Sector
Primary listing
Employees
172
Headquarters
Website
ClearPoint Neuro Metrics
BasicAdvanced
$269M
-
-$0.90
1.07
-
Price and volume
Market cap
$269M
Beta
1.07
52-week high
$30.10
52-week low
$8.60
Average daily volume
991K
Financial strength
Current ratio
5.908
Quick ratio
4.941
Long term debt to equity
205.346
Total debt to equity
207.823
Interest coverage (TTM)
-9.37%
Profitability
EBITDA (TTM)
-21.481
Gross margin (TTM)
61.38%
Net profit margin (TTM)
-69.08%
Operating margin (TTM)
-65.36%
Effective tax rate (TTM)
-0.22%
Revenue per employee (TTM)
$210,000
Management effectiveness
Return on assets (TTM)
-22.06%
Return on equity (TTM)
-95.64%
Valuation
Price to revenue (TTM)
6.947
Price to book
9.51
Price to tangible book (TTM)
40.2
Price to free cash flow (TTM)
-10.505
Free cash flow yield (TTM)
-9.52%
Free cash flow per share (TTM)
-0.863
Growth
Revenue change (TTM)
17.78%
Earnings per share change (TTM)
28.89%
3-year revenue growth (CAGR)
21.62%
10-year revenue growth (CAGR)
23.19%
3-year earnings per share growth (CAGR)
9.89%
10-year earnings per share growth (CAGR)
-14.81%
What the Analysts think about ClearPoint Neuro
Analyst ratings (Buy, Hold, Sell) for ClearPoint Neuro stock.
ClearPoint Neuro Financial Performance
Revenues and expenses
ClearPoint Neuro Earnings Performance
Company profitability
ClearPoint Neuro News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for ClearPoint Neuro stock?
ClearPoint Neuro (CLPT) has a market cap of $269M as of April 08, 2026.
What is the P/E ratio for ClearPoint Neuro stock?
The price to earnings (P/E) ratio for ClearPoint Neuro (CLPT) stock is 0 as of April 08, 2026.
Does ClearPoint Neuro stock pay dividends?
No, ClearPoint Neuro (CLPT) stock does not pay dividends to its shareholders as of April 08, 2026.
When is the next ClearPoint Neuro dividend payment date?
ClearPoint Neuro (CLPT) stock does not pay dividends to its shareholders.
What is the beta indicator for ClearPoint Neuro?
ClearPoint Neuro (CLPT) has a beta rating of 1.07. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.